MYD88 and diabetes mellitus: This suggests that inhibition of leukocyte mediated killing of endothelial cells in animals lacking TLR2/4 is mediated via a MyD88-independent pathway, but clearly indicates that MyD88 is a factor in diabetes-induced leukocyte activation.